RaNA gets rights to use Santaris' LNA technology

Santaris Pharma A/S (Horsholm, Denmark) granted RaNA Therapeutics Inc. (Cambridge, Mass.) rights to use Santaris' locked nucleic acid (LNA) technology to discover and develop RNA-targeted therapies ag...